Skip to content

Early Identification and Prediction of Deterioration Risk in Non-High-Risk Acute Pulmonary Embolism Patients Based on Pulmonary Artery CTA Radiomics

Early Identification and Prediction of Deterioration Risk in Non-High-Risk Acute Pulmonary Embolism Patients Based on Pulmonary Artery CTA Radiomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126662
Enrollment
Unknown
Registered
2026-06-12
Start date
2026-01-09
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute non-high-risk pulmonary embolism

Interventions

Sponsors

Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Admission with acute non-high-risk pulmonary embolism; 3. It has complete follow-up data and can be followed up until 30 days after the diagnosis of pulmonary embolism and after the endpoint event is clarified; 4. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Chronic or recurrent pulmonary embolism; 2. Failure to complete pulmonary artery CTA evaluation or lack of original DICOM data from pulmonary artery CTA; 3. Having received thrombolytic therapy prior to admission; 4. Poor quality of CTA images; 5. Presence of other pulmonary artery obstructive vascular diseases (e.g., pulmonary artery tumors, etc.); 6. Comorbidity with other cardiovascular diseases (e.g., congenital heart disease, cardiomyopathy, valvular disease, etc.); 7. Inability to meet the 30-day post-admission follow-up requirement.

Design outcomes

Primary

MeasureTime frame
Predictive performance of a risk prediction model based on pulmonary artery CTA radiomics for short-term deterioration tendency in non-high-risk acute pulmonary embolism patients, compared with traditional clinical prognostic assessment tools PESI and sPESI;

Countries

China

Contacts

Public ContactZhou Xiaoming

Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College

zhouxmcmu@163.com+86 10 88396849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026